Get started Log in

JANX — Janux Therapeutics News Story

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Market Cap
$1.04bn
Enterprise Value
$72.08m
Revenue
$10.00m

Brief: Janux Therapeutics Q4 Basic EPS USD -0.51

Janux Therapeutics

26/02/2026 21:01

Feb 26 (Reuters) - Janux Therapeutics Q4 operating expenses USD 42.401 million.

Q4 net income USD -42.401 million

Q4 operating income USD -42.401 million

Recent news on Janux Therapeutics

Janux Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
06/08/2026 21:59
Janux Therapeutics Q2 net loss narrows as expenses fall
06/08/2026 21:19
Brief: Janux Therapeutics Q2 Basic EPS USD -0.35
06/08/2026 21:03
Janux Therapeutics Q1 net loss widens on higher expenses
07/05/2026 21:50
Brief: Janux Therapeutics Q1 Basic EPS USD -0.39
07/05/2026 21:01